Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)

Background Palmoplantar psoriasis has significant physical and emotional impact on patients and can be difficult to treat. Objective To evaluate the efficacy of ixekizumab in the treatment of patients with moderate‐to‐severe plaque psoriasis and moderate‐to‐severe non‐pustular palmoplantar involveme...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2017-10, Vol.31 (10), p.1686-1692
Hauptverfasser:	Menter, A., Warren, R.B., Langley, R.G., Merola, J.F., Kerr, L.N., Dennehy, E.B., Shrom, D., Amato, D., Okubo, Y., Reich, K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - therapeutic use Dermatologic Agents - therapeutic use Double-Blind Method Etanercept - therapeutic use Female Humans Male Middle Aged Placebos Psoriasis - drug therapy Psoriasis - pathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!